Diversified science and technology company Danaher (NYSE: DHR) will be reporting earnings this Tuesday before market hours. Here’s what to look for.
Danaher beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $5.74 billion, flat year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and an impressive beat of analysts’ EPS estimates.
Is Danaher a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Danaher’s revenue to grow 1.7% year on year to $5.84 billion, a reversal from the 2.9% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.64 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Danaher has missed Wall Street’s revenue estimates twice over the last two years.
With Danaher being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, the whole sector has been hit hard over the last month as stocks in Danaher’s peer group are down 2.3% on average. Danaher is down 3% during the same time and is heading into earnings with an average analyst price target of $248.53 (compared to the current share price of $190.53).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.